BioPharma
Bora – Corealis Collaborate for Oral Solid Dose Development
Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization – CDMO, Corealis Pharma Inc., have gone on to enter into a strategic alliance so...
BioPharma
Successful Lab Design: Teams, Communication and Expertise
When we state that lab space happens to be a really exciting possibility, people don't find it surprising. Unfortunately, most laboratories don't have many possibilities to build the kind of place that continues to improve the technological aspect, resolve...
BioPharma
Lab Efficiency And Safety Through Smart Inventory Control
Inventory management is the work that laboratorians do on a daily basis that is both the most important and the most loathed. This is because inventory management is both the most essential and the most disliked duty. However, ineffective...
Clinical Trials
Eli Lilly & IU Join Hands to Expand Clinical Trials Access
A new agreement as per which Eli Lilly and Company is going to offer almost $40 million to Indiana University - IU has come to the fore. As Eli Lilly & IU join hands to expand access to clinical...
BioPharma
IQVIA Agentic AI Platform Builds New Capabilities with AWS
IQVIA, known across the life sciences industry for its clinical research operations, commercial analytics, and health-data expertise, has entered a strategic collaboration with Amazon Web Services (AWS), naming AWS as its Preferred Agentic Cloud Provider. Announced during AWS re:Invent,...
News
Industrial Boiler Water Treatment: Best Practices For Modern Plant Operations
Industrial boilers sit at the center of many plant operations, from heating and power to a wide range of industrial process needs. Because they run for long stretches, they depend on steady care. Water treatment is one of the...
Drug Research
Regeneron Looks to Infusing More Funds into Gene Editing
Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025, so as to create an experimental program pertaining to rare liver and lung disease.
At the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















